Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-26 @ 12:46 AM
Study NCT ID:
NCT05079360
Status:
WITHDRAWN
Last Update Posted:
2023-03-24
First Post:
2021-10-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
Sponsor:
Veru Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-05-26
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-01
First Submit QC Date:
None
Study First Post Date:
2021-10-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-22
Last Update Post Date:
2023-03-24
Last Update Post Date Type:
ACTUAL